Washington · 2025–26 Regular Sessions · Bill
HB 2613: Compounded medications
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2613 is a bill introduced in the Washington House on January 21, 2026. According to its official title, it concerns: Establishing safety and regulatory requirements for compounded medications. Primary sponsor: My-Linh Thai (D). It lists 5 additional sponsors. Most recent recorded action (January 21, 2026): First reading, referred to Health Care & Wellness.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official title
AN ACT Relating to establishing safety and regulatory requirements for compounded medications;
Nonpartisan staff bill reports (analyses) are available on the official bill page.
Sponsors
Sponsors by party (alphabetical): Democratic 6
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| My-Linh Thai | Primary sponsor | Democratic | House | 41 |
| Davina Duerr | Co-sponsor | Democratic | House | 1 |
| Natasha Hill | Co-sponsor | Democratic | House | 3 |
| Timm Ormsby | Co-sponsor | Democratic | House | 3 |
| Lisa Parshley | Co-sponsor | Democratic | House | 22 |
| Sharon Tomiko Santos | Co-sponsor | Democratic | House | 37 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- First reading, referred to Health Care & Wellness.